Patent 11634486 was granted and assigned to Bluefin Biomedicine on April, 2023 by the United States Patent and Trademark Office.
Disclosed herein are anti-Seizure Related 6 Homolog Like 2 (SEZ6L2) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.